Wilson Therapeutics Interim Report January 1 – March 31, 2016

STOCKHOLM--(BUSINESS WIRE)--Regulatory News:

January 1 – March 31, 2016

· Net sales amounted to SEK 0.0 M (0.0).

· Loss for the period was SEK 22.8 M (loss: 13.8)
MORE ON THIS TOPIC